Chlorine in PDB 5oye: GH5 Endo-Xyloglucanase From Cellvibrio Japonicus

All present enzymatic activity of GH5 Endo-Xyloglucanase From Cellvibrio Japonicus:
3.2.1.151;

The structure of GH5 Endo-Xyloglucanase From Cellvibrio Japonicus, PDB code: 5oye was solved by M.Attia, C.E.Nelson, W.A.Offen, N.Jain, J.G.Gardner, G.J.Davies, H.Brumer, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	81.83 / 1.90
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	55.343, 95.830, 157.208, 90.00, 90.00, 90.00
R / Rfree (%)	23.4 / 30

The binding sites of Chlorine atom in the GH5 Endo-Xyloglucanase From Cellvibrio Japonicus (pdb code 5oye). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the GH5 Endo-Xyloglucanase From Cellvibrio Japonicus, PDB code: 5oye:

Chlorine binding site 1 out of 1 in the GH5 Endo-Xyloglucanase From Cellvibrio Japonicus


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of GH5 Endo-Xyloglucanase From Cellvibrio Japonicus within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl511 b:80.8 occ:1.00 OG1 A:THR367 3.1 60.7 1.0 N A:GLU364 3.3 58.9 1.0 O A:HOH611 3.4 64.8 1.0 CB A:GLU364 3.5 60.3 1.0 CA A:GLU364 3.7 50.5 1.0 O A:GLU364 3.8 49.7 1.0 C A:GLU364 3.9 50.9 1.0 OE1 A:GLU364 3.9 52.2 0.5 N A:GLY363 4.0 43.9 1.0 N A:THR367 4.2 42.8 1.0 CB A:THR367 4.2 48.5 1.0 CG A:GLU364 4.3 61.6 1.0 C A:GLY363 4.4 55.6 1.0 C A:TRP362 4.5 46.1 1.0 CA A:GLY363 4.6 48.8 1.0 CD A:GLU364 4.6 53.8 0.5 CB A:ALA366 4.7 56.3 1.0 N A:ALA366 4.7 53.4 1.0 N A:GLU365 4.8 52.3 1.0 CA A:TRP362 4.8 51.2 1.0 CA A:THR367 4.8 47.5 1.0

M.A.Attia, C.E.Nelson, W.A.Offen, N.Jain, G.J.Davies, J.G.Gardner, H.Brumer. In Vitro and in Vivo Characterization of Threecellvibrio Japonicusglycoside Hydrolase Family 5 Members Reveals Potent Xyloglucan Backbone-Cleaving Functions. Biotechnol Biofuels V. 11 45 2018.
ISSN: ESSN 1754-6834
PubMed: 29467823
DOI: 10.1186/S13068-018-1039-6